NEW YORK (GenomeWeb) – Abbott said Wednesday that its fourth quarter diagnostic revenues grew 3 percent year over year on a reported basis and 7 percent on an organic basis to $1.96 billion from $1.91 billion in the year-ago period.

For the three months ended Dec. 31, 2018, Abbott reported worldwide revenues of $7.77 billion, up 2 percent from $7.59 billion a year ago, but lower than the average Wall Street estimate of $7.82 billion. Sales increased 6 percent year over year on an organic basis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.